INFUSE Olefin Block Copolymers (OBCs) versus and s Performance Differences, Benefits, and Potential Value Propositions Dow.com 1
Materials Tested Material OBC 65 Shore A OBC 45 Shore A 7 Shore A 5 Shore A 65 Shore A OBC 77 Shore A Description OBC/HDPE/oil/CaCO 3 1/45/125/1 phr OBC/NORDEL IP 477/HDPE/oil/CaCO 3 5/5/25/16/1 phr compound with PP, oil, and filler compound with PP, oil, and filler Plasticized PVC Neat resin Oil-extended thermoplastic elastomers (TPEs) based on INFUSE 91 OBC and styrene ethylene butylene styrene () are compared along with a flexible PVC () of similar hardness Comparisons are also made using OBC, which is used as a general proxy for any simple blends of OBCs with other polyolefin thermoplastics (e.g., PP, HDPE, LDPE) Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 2
Potential Benefits of OBC Elastomers Property Durability Animal fat resistance Durability Animal blood resistance Durability UV resistance Stain resistance Colorability Anti-mold/Anti-microbial Oil migration resistance Injection molding cycle time Volatile Organic s Abrasion resistance Wet coefficient of friction Oil-extended OBC s versus OBC/PP or PE Simple Blends versus Shore A 4-8 Shore A 75+ Potential Applications Meat packing boots, conveyor belts, hunting boots Meat packing boots, conveyor belts, hunting boots Outdoor/marine furniture Food contact articles Consumer durables Appliance gaskets, marine furniture Food lids, infant feeding products Overmolded goods, toys Manufacturing Boots Boots, grips, mats Carbon and energy footprint -- Advantaged performance of OBC materials Advantaged performance of comparative material Similar performance Not tested NOTE: Potential properties list is not exhaustive, other benefits and differences may exist Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 3
Durability Animal Fat Resistance Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 OBC 65 Sh A Control Lard 3 months Lard 12 months Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 7 Sh A Control Lard 3 months Lard 12 months 2 4 6 8 1, 1,2 2 4 6 8 1, 1,2 Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 Control Lard 3 months Lard 12 months 2 4 6 8 1, 1,2 Tensile properties of compounds after incubating in pork fat (lard) at 37 C for up to 1 year OBC Stable Small degree of plasticization Significant embrittlement Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 4
Durability Animal Fat Resistance Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 OBC Control Lard 3 months Lard 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 5 Sh A Control Lard 3 months Lard 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1,8 1,5 1,2 9 6 3 Control Lard 3 months Lard 12 months OBC 45 Sh A Tensile properties of compounds after incubating in pork fat (lard) at 37 C for up to 1 year Neat OBC Stable OBC Stable Some plasticization 2 4 6 8 1, 1,2 Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 5
Durability Animal Blood Resistance 1,4 1,2 OBC 65 Sh A 1,4 1,2 7 Sh A Tensile Stress (psi) 1, 8 6 4 2 Control Blood 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1, 8 6 4 2 Control Blood 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1,4 1,2 1, 8 6 4 2 Control Blood 12 months 2 4 6 8 1, 1,2 Tensile properties of compounds after incubating in bovine blood at 4 C for up to 1 year No significant changes in any of the materials Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 6
Durability Animal Blood Resistance 1,4 1,2 OBC 1,4 1,2 5 Sh A Tensile Stress (psi) 1, 8 6 4 2 Control Blood 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1, 8 6 4 2 Control Blood 12 months 2 4 6 8 1, 1,2 Tensile Stress (psi) 1,4 1,2 1, 8 6 4 2 Control Blood 12 months OBC 45 Sh A 2 4 6 8 1, 1,2 Tensile properties of compounds after incubating in bovine blood at 4 C for up to 1 year No significant changes in any of the materials Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 7
Durability UV Resistance Before UV Exposure OBC OBC 65 Sh A 7 Sh A 65 Shore A After 5 hours UV Exposure (15 mw/cm 2 ) OBC OBC 65 Sh A 7 Sh A 65 Shore A Appearance after UV aging: Neat OBC and OBC Slight yellowing (can be reduced with addition of UV stabilizers (2) ) Some yellowing and spotting Severe yellowing/browning and cracking Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. (2) The addition of an ultraviolet light (UV) stabilizer to a resin does not completely eliminate the effects of UV exposure; it is only intended to slow down the rate at which these effects occur. Actual results may vary depending on application and other factors such as resin color, transparency and additives. Therefore, actual end-use testing is recommended. 8
Stain Resistance a* 1 8 6 4 2 - -2 Ketchup Mustard Blueberry Color change after 3 days of exposure to common food staining comestibles: Neat OBC has the least color change -4 35 3 25 2 INFUSE 91 OBC 45 Sh A 5 Sh A INFUSE 91 OBC 65 Sh A 7 Sh A INFUSE 91 OBC Ketchup Mustard Blueberry Similar stain resistance for oil-extended compounds with either OBCs or has the most color change b* 15 1 5 - -a +b -5 INFUSE 91 OBC 45 Sh A 5 Sh A INFUSE 91 OBC 65 Sh A 7 Sh A INFUSE 91 OBC -b +a Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 9
Colorability 1. Color Saturation.8.6.4.2..5 wt% Red MB 3 wt% Red MB OBC OBC 45 Sh A 5 Sh A 7 Sh A Color saturation determined by difference in color of sample to color of 1% color masterbatch Sample color with addition of color masterbatch: Color saturation at significantly lower color masterbatch loading for Neat OBC (no oil) Similar color saturation for oil-extended compounds with either OBCs or Similar results for red, blue, and green color masterbatches Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 1
Anti-Microbial Performance OBC 65 Sh A OBC 45 Sh A 5 Sh A 7 Sh A OBC SAMPLE PINK STAIN TEST ASTM G-21 FUNGAL GROWTH OBC 65 Sh A Trace of Stain Traces of Growth OBC 45 Sh A Trace of Stain High Growth 5 Sh A Trace of Stain Traces of Growth 7 Sh A Trace of Stain Traces of Growth Light Stain High Growth OBC No Stain No Growth Neat OBC significantly better than oil-extended compounds or No biocide needed No significant differences between oil-extended OBC and oil-extended compounds Biocide recommended (i.e., VINYZENE Biocide) has poor microbial resistance Biocide required Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 11
Extractables Hexane Extractables Olive Oil Extractables 1. Hexane, 5 C, 2 hrs 1. Olive Oil, 4 C, 1 days Normalized Extractables.8.6.4.2 Normalized Extractables.8.6.4.2. OBC 7 Sh A. OBC OBC 65 Sh A Neat INFUSE OBC has significantly lower extractables than oil-extended compounds with OBCs or No significant differences between oil-extended OBC and oil-extended compounds Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 12
Injection Molding Cycle Time 4 35 Cycle Time (s) 3 25 2 15 1 5 OBC OBC 45 Sh A 5 Sh A OBC 65 Sh A 7 Sh A Injection molding cycle time for 4 x 6 x.125 inch part: Comparable cycle times between OBC compounds, compounds, and Slightly higher cycle time for neat OBC due to low MI Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 13
Volatile Organic s 1 Normalized Volatiles (18 C, 1 min) 8 6 4 2 7 Sh A OBC 45 Sh A OBC 65 Sh A 5 Sh A VOC reduction for improved air quality in manufacturing environments: INFUSE OBC blends without oil have very low VOCs (data not shown here) Comparable volatiles between oil-extended OBC and compounds Significantly higher volatiles for Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 14
Abrasion Resistance DIN Abrasion 6 DIN Abrasion Relative Volume Loss (mm 3 ) 5 4 3 2 1 OBC 45 Sh A 5 Sh A OBC 65 Sh A 7 Sh A OBC Improved durability with better abrasion resistance: Neat OBC offers the best abrasion resistance OBC compounds have better DIN abrasion resistance than compounds or Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 15
Coefficient of Friction 2. ASTM D 1894 1.8 Dry Kinetic COF on Stainless Steel 1.6 1.4 1.2 1..8.6.4.2 Wet Kinetic. OBC 45 Sh A 5 Sh A OBC 65 Sh A 7 Sh A OBC COF as measured on mirror-finish plaques on stainless steel: OBC compounds have higher wet and dry COF than compounds or COF on other surfaces not measured at present Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 16
Life Cycle Analysis Cradle-to-Gate LCA of OBC versus SBC was completed Elementary Flows Emissions Emissions Resources Extraction / Mining Ancillary Materials Refining Production Conversion Use Disposal End of Life Emissions Energy Recycling Cradle-to-Gate (Eco-Profile) Cradle-to-Grave (Full Life Cycle) 17
Life Cycle Analysis 1..8 Normalized Value per 1 kg of Product.6.4.2. CED, MJ GWP, kg CO 2 eq AP, kg SO 2 eq EP, kg PO 4 eq OBC copolymer CED = Cumulative Energy Demand GWP = Global Warming Potential AP = Acidification Potential EP = Eutrophication Potential Production of 1 kg OBC uses ~2% less energy and produces ~4% less CO 2 equivalents than production of 1 kg Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 18
Summary Simple blends of INFUSE OBCs with other thermoplastic polyolefins (i.e., PP, HDPE, LDPE) provide materials over a range of hardness and flexibility and have several benefits over both -based TPEs and TPEs based on OBC have several potential benefits versus, including improved durability to UV exposure and fatty materials, better flexibility over a range of temperatures, stain resistance, and lower VOCs for a cleaner manufacturing environment TPEs based on OBC provide an alternative to -based TPEs with many comparable properties, potentially lower cost, and an improved Eco-profile 19
General Reference Properties Property / Material OBC OBC - 65 Sh A OBC - 45 Sh A - 7 Sh A - 5 Sh A Hardness (Shore A, 1 s) 78 66 43 71 72 51 Density (g/cm 3 ).877 1.6 1.6 1.36 1.18 1.18 Compression Set, 22 hrs, 23 C Compression Set, 22 hrs, 4 C Compression Set, 22 hrs, 7 C Tensile Modulus, 1% secant (psi) Tensile Modulus, 1% secant (psi) 24 24 27 23 11 27 49 49 62 62 36 23 69 54 77 79 47 67 25 43 14 115 136 21 67 28 146 781 43 21 Tensile Strength (psi) 2, 766 57 1,32 1,112 793 Elongation at Break (%) 9 1,138 1,97 31 747 73 Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 2
General Properties DMS Rheology Complex Viscosity (Pa-s) 1,, 1, 1, 1, Oscillatory Shear at 19 C OBC 7 Sh A 5 Sh A OBC 65 Sh A OBC 45 Sh A 1.1 1 1 1 Frequency (rad/s) Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 21
General Properties Tensile Properties Tensile Stress (MPa) 16 14 12 1 8 6 OBC 7 Sh A 5 Sh A OBC 65 Sh A OBC 45 Sh A 4 2 2 4 6 8 1, 1,2 Data per tests conducted by Dow. Test protocols and additional information available upon request. Properties shown are typical, not to be construed as specifications. Users should confirm results by their own tests. 22
Thank You
For more information on products, innovations, expertise, and other services available to you from Dow Elastomers, contact us as indicated below. North America Europe/Middle East + 8 3694 6367 dow.com U.S. & Canada 1 8 441 4369 + 31 115 672626 dowelastomers.com 1 989 832 1426 Italy + 8 783 825 Mexico + 1 8 441 4369 South Africa + 8 99 578 Latin America Argentina + 54 11 4319 1 Asia Pacific + 8 7776 7776 Brazil + 55 11 5188 9 + 63 7965 5392 Colombia + 57 1 219 6 Mexico + 52 55 521 47 NOTICE: Any photographs of end-use applications in this document represent potential end-use applications but do not necessarily represent current commercial applications, nor do they represent an endorsement by Dow of the actual products. Further, these photographs are for illustration purposes only and do not reflect either an endorsement or sponsorship of any other manufacturer for a specific potential end-use product or application, or for Dow, or for specific products manufactured by Dow. NOTICE: No freedom from infringement of any patent owned by Dow or others is to be inferred. Because use conditions and applicable laws may differ from one location to another and may change with time, the Customer is responsible for determining whether products and the information in this document are appropriate for the Customer s use and for ensuring that the Customer s workplace and disposal practices are in compliance with applicable laws and other governmental enactments. Dow assumes no obligation or liability for the information in this document. NO WARRANTIES ARE GIVEN; ALL IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE ARE EXPRESSLY EXCLUDED. NOTICE: If products are described as experimental or developmental : product specifications may not be fully determined; (2) analysis of hazards and caution in handling and use are required; (3) there is greater potential for Dow to change specifications and/or discontinue production; and (4) although Dow may from time to time provide samples of such products, Dow is not obligated to supply or otherwise commercialize such products for any use or application whatsoever. NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: Dow will not knowingly sell or sample any product or service ( Product ) into any commercial or developmental application that is intended for: a. long-term or permanent contact with internal bodily fluids or tissues. Long-term is contact which exceeds 72 continuous hours; b. use in cardiac prosthetic devices regardless of the length of time involved ( cardiac prosthetic devices include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass-assisted devices); c. use as a critical component in medical devices that support or sustain human life; or d. use specifically by pregnant women or in applications designed specifically to promote or interfere with human reproduction. Dow requests that customers considering use of Dow products in medical applications notify Dow so that appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer to determine that the Dow product is safe, lawful, and technically suitable for the intended use. DOW MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW PRODUCT FOR USE IN MEDICAL APPLICATIONS. This document is intended for global use. Published July, 213. 213 The Dow Chemical Company Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Responsible Care is a service mark of the American Chemistry Council. Dow is a partner in the American Chemistry Council Responsible Care initiative. Form No. 788-131-713 SMG 24